do Nascimento Israel Junior Borges, Harries Matthew, Rocha Vanessa Barreto, Thompson Jacqueline Y, Wong Chun Hoong, Varkaneh Hamed Kord, Guimarães Nathália Sernizon, Rocha Arantes Alair Junior, Marcolino Milena Soriano
Department of Internal Medicine, University Hospital and School of Medicine, Federal University of Minas Gerais, Brazil.
Department of Internal Medicine, School of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Int J Trichology. 2020 Jul-Aug;12(4):147-155. doi: 10.4103/ijt.ijt_19_20. Epub 2020 Sep 19.
Patients with major presentations of alopecia experience physically harmful effects and psychological comorbidities, such as depression and anxiety. Oral minoxidil (OM) has been suggested by dermatologists as a potential remedy; however, its effectiveness remains unclear. This systematic review aims to collate published studies and to analyze the effect of OM among patients diagnosed with any type of alopecia. For this systematic review, Medline/PubMed, Cochrane Central, EMBASE, Web of Sciences, and Latin American and Caribbean Health Sciences Information System were searched for relevant studies from inception to September 21, 2019. Of 1960 studies retrieved in several electronic databases and three additional records identified though reference list from potentially eligible studies, nine studies (one randomized controlled trial and eight nonrandomized controlled trials) met the requirements and were used in our analysis. Although we found positive effects in favor of OM, this should be interpreted cautiously due to very low quality of the evidence of outcomes in the selected studies. Definitive conclusions are not possible without high-quality trials. This review has highlighted the absence of high-quality randomized controlled trials evaluating OM in the treatment of various types of alopecia. Given the mild adverse events of OM, future studies should also analyze doses and duration to maximize efficacy and decrease side effects.
患有严重脱发症状的患者会遭受身体上的有害影响以及心理上的共病,如抑郁和焦虑。皮肤科医生已建议口服米诺地尔(OM)作为一种潜在的治疗方法;然而,其有效性仍不明确。本系统评价旨在整理已发表的研究,并分析OM对诊断为任何类型脱发患者的疗效。对于本系统评价,检索了Medline/PubMed、Cochrane Central、EMBASE、Web of Sciences以及拉丁美洲和加勒比健康科学信息系统,以查找从创刊至2019年9月21日的相关研究。在多个电子数据库中检索到的1960项研究以及通过潜在符合条件研究的参考文献列表确定的另外三项记录中,有九项研究(一项随机对照试验和八项非随机对照试验)符合要求并用于我们的分析。尽管我们发现了支持OM的积极效果,但由于所选研究结果的证据质量非常低,对此应谨慎解释。没有高质量的试验就不可能得出明确的结论。本评价突出了缺乏评估OM治疗各种类型脱发的高质量随机对照试验。鉴于OM的不良事件较轻,未来的研究还应分析剂量和疗程,以最大限度地提高疗效并减少副作用。